FDA Investigator: Yonggang Wang
- Yonggang Wang first started conducting FDA inspections in 2018, with the last inspection in 2023. Over that time, Yonggang Wang has conducted 7 inspections at 7 companies across 7 sites.
Get Yonggang Wang's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Grifols Therapeutics, Clayton | September 2023
Available Now - $199
Yonggang Wang
Biologics Form 483
FDA 483 Octapharma Produktionsgesellschaft Deutschland mbH, Springe | 2023
Out-of-stock
Yonggang Wang
Biologics Form 483
FDA 483 Octapharma Pharmazeutika Produktionsgesellschaft m.b.H., Vienna | 2022
Out-of-stock
Yonggang Wang
Biologics Form 483
FDA 483 CSL Behring Australia Proprietary Ltd, Broadmeadows | 2019
Out-of-stock
Yonggang Wang
Biologic Form 483
FDA 483 Baxalta Belgium Manufacturing SA, Lessines | 2019
Out-of-stock
Yonggang Wang
Biologic Form 483
FDA 483 CSL Behring L.L.C., Bradley | 2018
Out-of-stock
Yonggang Wang
Biologic Form 483
FDA 483 Baxalta US Inc., Social Circle | 2018
Out-of-stock
Yonggang Wang
Biologic Form 483
Co-Investigators (15)
- Kula N. Jha, FDA Investigator
- Bradley J. Dworak, FDA Investigator
- Laura Fontan, FDA Investigator
- Zainab Y. Mansaray-Storms, FDA Investigator
- Roger F. Zabinski, FDA Investigator
- Gene D. Arcy, FDA Investigator
- Scott T. Ballard, FDA Investigator
- Prabhu P. Raju, FDA Investigator
- Mizanne E. Lewis, FDA Investigator
- Gregory A. Price, FDA Investigator
- Lily Y. Koo, FDA Investigator
- Omotunde O. Osunsanmi, FDA Investigator
- Deborah M. Trout, FDA Investigator
- Michael C. Kennedy, FDA Investigator
- Silvia Wanis, FDA Investigator